Plain-English translation of NCT06623071 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hepatitis B research guide →This trial is testing a new laboratory tool called the Accupower HBV Performance Evaluation Quant Kit, which measures the amount of hepatitis B virus in a patient's blood. Researchers want to see how well this new measurement method works compared to existing tests. If successful, this tool could help doctors better monitor and treat people with hepatitis B.
Accurate measurement of hepatitis B virus levels is essential for doctors to decide on treatment and track how well treatment is working. This trial exists to make sure the new measurement tool is reliable and accurate for patients who need it.
You would visit the research center and provide a blood sample so researchers can test it using the new hepatitis B measurement kit. The study involves 45 participants total. Your participation helps evaluate whether this new testing tool works well and could be useful for other patients with hepatitis B in the future.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
France
Collaborators
BIONEER Corporation
Enrollment target
~45 participants
Started
October 2024
Primary completion
March 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sabrina KALI, Dr.
CerbaXpert